Company Number: 13934955

Analysis Date: 2025-07-29 17:43 UTC

Financial Health Assessment Report for BLOODS UK LIMITED

---

1. Financial Health Score: C

Explanation:
BLOODS UK LIMITED shows significant improvement from the prior years, moving from a distressed financial position with negative net assets to a positive net asset base. However, the company still operates on tight working capital margins and a modest asset base, typical of a micro-entity. The recovery is promising but stability and growth need to be consolidated. Hence, a grade of C reflects a company recovering but still with some caution warranted.

---

2. Key Vital Signs

Metric	2024 (£)	2023 (£)	Interpretation
Fixed Assets	35,859	45,984	Decrease in fixed assets suggests asset disposals or depreciation; no major new investments.
Current Assets	58,779	(10,704)	Strong positive turnaround from negative current assets, indicating improved liquidity.
Current Liabilities	54,048	94,457	Reduced short-term debts, lowering immediate financial pressure.
Net Current Assets	4,731	(94,891)	Positive working capital now, a vital "healthy cash flow" indicator, improving operational health.
Net Assets (Shareholders’ Funds)	40,590	(48,907)	From negative to positive equity signals a "recovery symptom" indicating improved solvency.
Average Employees	2	2	Stable workforce size suggests consistent operational scale.

---

3. Diagnosis

The financial "symptoms" from previous years showed serious distress: large negative working capital and net liabilities suggested the company was "in financial shock," struggling to cover short-term obligations and with eroded shareholder equity.

However, the 2024 accounts reveal a marked improvement:

• Liquidity: Positive net current assets indicate improved liquidity, meaning the company now has enough short-term assets to cover immediate liabilities. This is akin to a patient who was previously dehydrated but now shows signs of hydration and improved circulation.

• Solvency: Net assets turning positive is a critical sign that the company is no longer "in the red," reflecting an improved balance sheet and potential for sustained operations.

• Operational Scale: Maintaining a small but stable employee base indicates operational continuity without overextension.

• Asset Base: Fixed assets have decreased, which may reflect asset sales or write-downs to shore up liquidity, a typical "emergency measure" in financial recovery.

The company operates in the technical testing and analysis sector, providing private blood testing services, which is a niche medical-related service with potential demand stability.

---

4. Recommendations

To continue strengthening the financial health and avoid relapse into distress, the following actions are advisable:

1. Cash Flow Management:
   Maintain tight control over working capital. Monitor receivables and payables closely to ensure liquidity remains positive. Aim to increase cash reserves to buffer against unexpected expenses.

2. Cost Control and Efficiency:
   Review operating expenses regularly to avoid unnecessary costs. With a small team, ensure productivity is optimized without overburdening staff.

3. Asset Utilization:
   Evaluate the fixed asset base for efficiency. If assets are underused, consider further disposals or upgrades that improve productivity without excessive capital outlay.

4. Growth Strategy:
   Explore opportunities to increase revenue within the existing market niche, such as expanding service offerings or enhancing marketing to capture more customers.

5. Financial Planning:
   Prepare regular financial forecasts to anticipate future funding needs. Consider potential external funding or shareholder investment if growth requires capital.

6. Governance and Compliance:
   Ensure timely filing of accounts and returns (which appears on track) and maintain clear communication with stakeholders to uphold confidence.

---

Medical Analogy Summary

BLOODS UK LIMITED has shown a remarkable "recovery" from a previous state of financial distress, akin to a patient who was critically ill but is now in stable condition. The company’s "vital signs" such as liquidity and solvency have improved, indicating a healthier financial state. However, like any recovering patient, vigilance is needed to maintain stability and promote sustained growth, preventing relapse into financial difficulty.

---